{
  "name": "Infectious Disease",
  "slug": "infectious-disease",
  "icon": "ü¶†",
  "color": "bg-red-100 text-red-800 border-red-200",
  "toc": [
    {
      "level": 1,
      "text": "CSF Profiles and MEP",
      "id": "csf-profiles-and-mep"
    },
    {
      "level": 1,
      "text": "Bacterial Meningitis",
      "id": "bacterial-meningitis"
    },
    {
      "level": 1,
      "text": "Viral Meningitis",
      "id": "viral-meningitis"
    },
    {
      "level": 1,
      "text": "Acute Flaccid Myelitis",
      "id": "acute-flaccid-myelitis"
    },
    {
      "level": 1,
      "text": "EV-71 related meningomyeloencephalitis",
      "id": "ev-71-related-meningomyeloencephalitis"
    },
    {
      "level": 1,
      "text": "Encephalitis",
      "id": "encephalitis"
    },
    {
      "level": 1,
      "text": "COVID-19 and Neurologic Sequelae",
      "id": "covid-19-and-neurologic-sequelae"
    }
  ],
  "html": "<h1 id=\"csf-profiles-and-mep\">CSF Profiles and MEP</h1><p><strong>Normal by Age:</strong></p><div class=\"table-wrap\"><table><tbody><tr><td></td><td><p><strong>WBC</strong></p></td><td><p><strong>Protein</strong></p></td><td><p><strong>Glucose</strong></p></td><td><p><strong>OP (cmH2O)</strong></p></td></tr><tr><td><p><strong>Neonates</strong></p></td><td></td><td></td><td></td><td></td></tr><tr><td><p><strong>Preterm</strong></p></td><td><p>0-25 </p></td><td><p>115 (65-150)</p></td><td><p>50 (24-63) mg/dL</p><p>55-105 % serum</p></td><td></td></tr><tr><td><p><strong>Term</strong></p></td><td><p>0-22</p></td><td><p>90 (20-170)</p></td><td><p>52 (34-119) mg/dL</p><p>44-128 % serum</p></td><td><p>0-8</p></td></tr><tr><td><p><strong>Children</strong></p></td><td><p>0-5</p></td><td><p>5-30 </p></td><td><p>50-75 (2/3 serum)</p></td><td><p>0-8 (&lt;2 yrs)</p><p>1-25 (&gt;=2 yrs)</p></td></tr><tr><td><p><strong>Adults</strong></p></td><td><p>0-5</p></td><td><p>20-40</p></td><td><p>45-90 (2/3 serum)</p></td><td><p>6-25</p></td></tr></tbody></table></div><p><strong>CSF Profile in Certain Infections:</strong></p><div class=\"table-wrap\"><table><tbody><tr><td></td><td><p><strong>WBC</strong></p></td><td><p><strong>Diff</strong></p></td><td><p><strong>Protein</strong></p></td><td><p><strong>Glucose</strong></p></td><td><p><strong>OP</strong></p></td><td><p><strong>Other</strong></p></td></tr><tr><td><p><strong>Bacterial</strong></p></td><td><p>100-5000</p></td><td><p>PMNs</p></td><td><p>50-100 (nl to high)</p></td><td><p>low</p></td><td><p>High</p></td><td><p>Partially treated ‚Äì cells usu high &lt;48 hours after tx, PMNs initially, may change to monos, glucose may normalize</p></td></tr><tr><td><p><strong>Viral</strong></p></td><td><p>10-100</p></td><td><p>Lymphs (can be PMNs in the first 24-48 hrs)</p></td><td><p>40-80 (nl to high)</p></td><td><p>nl</p></td><td><p>Nl-midly high</p></td><td></td></tr><tr><td><p><strong>Fungal</strong></p></td><td><p>20-500</p></td><td><p>PMNs earl, then monos/lymphs</p></td><td><p>50-300 (H)</p></td><td><p>low</p></td><td><p>High</p></td><td><p>Usu immunocompromised</p></td></tr><tr><td><p><strong>TB</strong></p></td><td><p>100-500</p></td><td><p>Monos and lymphs</p></td><td><p>50-300 (H)</p></td><td><p>V. Low</p></td><td><p>nl to high</p></td><td><p>Consider HIV concurrently</p></td></tr><tr><td><p><strong>Parainfectious encephalitis</strong></p></td><td><p>8-50</p></td><td><p>lymphs</p></td><td><p>15-75 (nl to H)</p></td><td><p>Nl</p></td><td><p>nl to high</p></td><td></td></tr><tr><td><p><strong>Carcinomatosis</strong></p></td><td><p>variable</p></td><td><p>Need cyto</p></td><td><p>Mildly high</p></td><td><p>Usu low</p></td><td><p>Usu high</p></td><td><p>Need cytology (10cc of CSF)</p></td></tr></tbody></table></div><p>What‚Äôs on the Meningitis Encephalitis Panel (MEP)?</p><p>BACTERIA: E. coli (strain K1 only), H. flu, Listeria monocytogenes, N. meningitidis, S. agalactiae (Group B Strep), S. pneumoniae VIRUSES*: CMV, Enterovirus, HSV-1, HSV-2, Parechovirus, VZV FUNGI: Cryptococcus neoformans/gattii</p><p>*Note: HHV-6 is also tested, but these results are not routinely reported since HHV-6 is more commonly detected due to chromosomal integration or reactivation as opposed to true infection, except in immunocompromised patients. If no HSV is detected but concern for this virus remains, continue acyclovir and repeat lumbar puncture in 2-4 days for HSV PCR. In neonates, swabs of eye/throat/rectum or vesicles for HSV culture and blood for HSV PCR should also be sent to improve diagnostic accuracy. CSF may be PCR negative in some enterovirus or parechovirus infections, so consider sending throat and rectal swabs and/or serum for enterovirus and/or parechovirus PCR to improve virus recovery.</p><h1 id=\"bacterial-meningitis\">Bacterial Meningitis</h1><p><strong>Clinical presentation:</strong></p><ul><li>Fevers</li><li>Seizures (this can be the only initial symptom at presentation in neonates and infants &lt;12 month ‚Äì <em>AAP says to strongly consider LP for even simple febrile seizure if poorly vaccinated and 6-12 mo)</em></li><li>Meningismus (nuchal rigidity, photophobia, headache, can test Brudzinski‚Äôs ‚Äì involuntary lifting of legs with neck flexion, Kernig‚Äôs ‚Äì hip and thigh flexed at 90 degrees results in painful extension at the knee) ‚Äì only 5-30% sensitive, but 95-100% specific. Unreliable/less sensitive in infants.</li><li>Etiology by age:</li></ul><div class=\"table-wrap\"><table><tbody><tr><td><p><strong>Neonate</strong></p></td><td><p>GBS, enteric GNegs (e.coli), listeria, </p></td></tr><tr><td><p><strong>1 mo to 23 mo</strong></p></td><td><p>N. men, strep pneumo, H. flu, E.coli, GBS</p></td></tr><tr><td><p><strong>&gt; 2 yo</strong></p></td><td><p>Strep pneumo, N. men, listeria (others: h. flu, GNegs)</p></td></tr></tbody></table></div><p><strong>Evaluation:</strong></p><ul><li>Antibiotics should not be delayed for testing if clinical suspicion is present</li><li>Procalcitonin (&gt;5.0 ug/L has sens 94%, spec 100% for bacterial meningitis)</li><li>CRP ‚Äì Normal CRP has high negative predictive value for bacterial meningitis</li><li>LP ‚Äì <strong>CT before if risk of increased ICP‚Ä¶ (suggestions based on adult study that have increased chance of abnormal neuroimaging)</strong></li><li>Papilledema</li><li>Focal neurologic findings</li><li>History of CNS disease</li><li>New onset seizures (within one week)</li><li>Symptoms of imminent herniation</li><li>+/- AMS, immunocompromised state</li></ul><ul><li>Initial CSF Testing</li><li>Cell count with diff, glucose, protein, bacterial culture, MEP</li></ul><p><strong>Treatment:</strong></p><p>¬∑ Role of steroids:</p><p>¬∑ Dexamethasone 0.6 mg/kg/day IV divided q6 x2-4 days (10mg q6 for adults) reduces sequelae (esp hearing loss) of H. flu and Strep pneumo</p><p>¬∑ Give steroids 10-20 minutes before antibiotics, less benefit if Rx already given, but the sooner the better. Do not delay antibiotics if steroids not available immediately.</p><p>¬∑ Antimicrobials (see dosing table below)</p><p>¬∑ Neonate: ampicillin and cefotaxime or ceftriaxone</p><p>¬∑ Children/Adults: ceftriaxone/cefotaxime and vanc (for resistant S. pneumo, not necessarily for Staph)</p><p>¬∑ Post-neurosurgery, CSF shunt, or penetrating trauma: cefepime/ceftazidime/meropenem and vanc</p><p>Ceftriaxone 50mg/kg/dose (max 2g) q12h</p><p>Cefepime 50mg/kg/dose (max 2g) q8h</p><p>Vancomycin 15mg/kg/dose q6h Goal trough 15-20</p><p>References:</p><p>¬∑ Infectious Disease Society of America. Practice Guidelines for the Management of Bacterial Meningitis.</p><h1 id=\"viral-meningitis\">Viral Meningitis</h1><p><strong>Clinical Presentation:</strong> same as bacterial above though course can be more indolent</p><p><strong>Evaluation:</strong></p><ul><li>LP (see profiles below)<ul><li>Viral testing:<ul><li>MEP (Meningitis Encephalitis Panel: PCR for e.coli, h.flu, listeria, n.meningitidis, GBS, S.pneumo, CMV, EV, HSV 1&amp;2, HHV6, parechovirus, VZV, Cryptococcus)</li></ul></li></ul></li><li>Etiology by season:<ul><li>Most common cause of viral meningitis ‚Äì EV (&gt;80% in children), late summer early fall predominance</li><li>Approximately 5% HSV (II&gt;I for meningitis ‚Äì opposite in encephalitis)</li><li>Failure to identify a specific pathogen is not uncommon</li></ul></li></ul><div class=\"table-wrap\"><table><tbody><tr><td><p><strong>Season</strong></p></td><td><p><strong>Meningitis</strong></p></td><td><p><strong>Encephalitis</strong></p></td><td><p><strong>Other</strong></p></td></tr><tr><td><p>Summer/Fall</p></td><td><p>EV</p><p>Parecho</p></td><td><p>EV</p><p>Parecho</p><p>West Nile Virus (WNV)</p><p>Amebic Encephalitis (Naegleria, Acanthamoeba, Balamuthia) </p></td><td><p>WNV ‚Äì throughout US, can cause AFP, affects deep gray structures, cerebellum</p><p>~50% of infants with EV and most with parechovirus meningitis have no pleocytosis</p><p>Parechovirus most common in &lt;6mo, can cause white matter encephalitis</p></td></tr><tr><td><p>Winter/Spring</p></td><td><p>Mumps</p><p>LCMV</p></td><td><p>Measles</p><p>Mumps</p></td><td></td></tr><tr><td><p>Any time</p></td><td><p>HSV</p><p>HIV</p></td><td><p>HSV, EBV, HIV, HHV6, VZV, Rabies</p></td><td><p>Detection of HHV-6 does not always signify acute infection as can be chromosomally integrated (1% of population) or reactivated</p></td></tr></tbody></table></div><p><strong>Treatment:</strong></p><ul><li>HSV ‚Äì IV acyclovir 10mg/kg q8h (children); IV acyclovir 20/kg q8h (neonates). Recommend IV hydration and close monitoring of Cr as can crystallize and cause AKI.</li></ul><h1 id=\"acute-flaccid-myelitis\">Acute Flaccid Myelitis</h1><p>Symptoms: &gt;90% with preceding mild URI or febrile viral illness. Acute onset flaccid paralysis of one or more extremities or cranial neuropathies (facial palsy, bulbar weakness, diplopia); can be asymmetric</p><p>DDx: Includes EV-68, EV-71, WNV, polio, MOGAD, NMO, spinal cord stroke</p><p>MRI: In enteroviral infections - Dorsal brainstem and longitudinally extensive spinal grey matter hyperintensity, usually non-enhancing, +/- nerve root enhancement</p><p>LP: Pleocytosis common</p><p>Tx: None proven to be effective. IVIG is used most widely. Steroids worsened outcome in some animal models but could be considered if large degree of spinal cord edema resulting in UMN deficits.</p><p>Full summary of recommendations: <a href=\"https://www.cdc.gov/acute-flaccid-myelitis/hcp/clinical-management.html\">https://www.cdc.gov/acute-flaccid-myelitis/hcp/clinical-management.html</a></p><h1 id=\"ev-71-related-meningomyeloencephalitis\">EV-71 related meningomyeloencephalitis</h1><p>Symptoms</p><p>¬∑ Fever, vomiting, ataxia, myoclonic jerks (especially during sleep), CN dysfunction</p><p>¬∑ Truncal hypotonia, limb weakness (AFM), urinary retention</p><p>¬∑ Autonomic dysfunction + acute cardiorespiratory collapse</p><p>o Arrythmias, pulmonary edema/hemorrhage</p><p>Testing</p><p>¬∑ LP</p><p>¬∑ CSF EV testing- low sensitivity (27%)</p><p>¬∑ EV rectum/throat/respiratory swab ‚Äì high sensitivity (95%)</p><p>o If no enterovirus is found, consider other possibilities (NMO, MOG, etc)</p><p>¬∑ MRI WWO at least of brain; usually C/T spine as well</p><p>o Sensitivity ~80%</p><p>o Most commonly dorsal rhomboencephalitis with T2 hyperintensity encircling 4th ventricle</p><p>o May show hyperintensity of the spinal grey matter</p><p>o Leptomeningeal enhancement (17%)</p><p>¬∑ ESR, CRP, WBC may be normal</p><p>Treatment</p><p>¬∑ None proven to alter outcome</p><p>¬∑ Typical practice has been to use IVIG in cases of brainstem encephalitis with autonomic dysfunction or acute flaccid myelitis</p><p>o Can consider steroids if refractory to IVIG</p><p>¬∑ Supportive care</p><p>o PT/OT/SLP +/- Rehab</p><p>o CR monitoring</p><p>o Post-void residuals</p><p>Prognosis (small study)</p><p>¬∑ Most children with resolution of symptoms by ~30 days</p><p>¬∑ Encephalomyelitis or cardiopulmonary failure ‚Äì may still have symptoms at 30 days</p><p>¬∑ Unclear long-term outcomes</p><p>References:</p><p>Taravilla C, P√©rez-Sebasti√°n I, Salido A, et al. Enterovirus A71 Infection and Neurologic Disease, Madrid, Spain, 2016. Emerging Infectious Diseases. 2019;25(1):25-32.</p><h1 id=\"encephalitis\">Encephalitis</h1><p><strong>Consider the following studies in suspected encephalitis in US Children:</strong></p><div class=\"table-wrap\"><table><tbody><tr><td><p><strong>Diagnostic Modality</strong></p></td><td><p><strong>Tier 1</strong></p></td><td></td><td><p><strong>Tier 2</strong></p></td></tr><tr><td></td><td><p>Common/Treatable Causes</p></td><td><p>Selected Testing Dependent on Risk Factors / Situation</p></td><td><p>Unexplained persistent or severe disease</p></td></tr><tr><td><p><strong>Procedures</strong></p></td><td><p>MRI Brain WWO +/- Spinal Cord</p><p>Lumbar Puncture</p><p>+/- EEG</p></td><td><p>Dilated ophtho exam</p></td><td><p>Consider repeat LP</p><p>Consider brain biopsy</p></td></tr><tr><td><p><strong>Serum Testing</strong></p></td><td><p>CBC, CRP, ESR or PCT, CMP</p><p>HSV/EV PCR (neonate)</p><p>+/- Bacterial Cx</p></td><td><p>WNV or other arboviral serologies</p><p>HIV Abs</p><p>EBV or CMV serologies</p><p>Autoimmune encephalopathy panel</p></td><td></td></tr><tr><td><p><strong>CSF Testing</strong></p></td><td><p>Cell count + Diff, glucose, protein</p><p>Culture</p><p>Meningoencephalitis panel</p></td><td><p>Autoimmune encephalopathy panel</p><p>OCBs</p><p>WNV or other arboviral serologies</p><p>Mycobacterial Cx + PCR</p><p>Wet Mount and ameba PCRs</p></td><td><p>Metagenomic sequencing</p></td></tr><tr><td><p><strong>Other Sites</strong></p></td><td><p>Surface swabs: HSV PCR (Neonate), EV (throat/rectal)</p></td><td><p>Respiratory specimen: Respiratory pathogen panel</p><p>Vesicles: EV, HSV, VZV PCR/CX</p><p>Utox</p></td><td><p>Brain tissue: HSV PCR, metagenomic sequencing</p></td></tr></tbody></table></div><p><strong>Directed differential of encephalitis:</strong></p><div class=\"table-wrap\"><table><tbody><tr><td><p><strong>Age</strong></p></td><td><p><strong>Established Causes</strong></p></td><td><p><strong>Rare Cause / Mimic</strong></p></td></tr><tr><td><p><strong>Neonates or infants</strong></p></td><td><p>HSV, CMV, EV, HPeV</p></td><td><p>Toxoplasma gondii, treponema pallidum, Zika</p></td></tr><tr><td><p><strong>Teens</strong></p></td><td><p>HIV, EBV, WNV</p></td><td><p>Treponema palllidum</p></td></tr><tr><td><p><strong>Unvaccinated</strong></p></td><td><p>Measles, mumps, rubella, VZV&lt; poliovirus</p></td><td></td></tr><tr><td><p><strong>Season</strong></p></td><td></td><td></td></tr><tr><td><p><strong>Summer or fall</strong></p></td><td><p>EV, WNV, LACV</p></td><td><p>Rickettsia, Ehrlichia, Anaplasma, Borrelia burgdorferi</p></td></tr><tr><td><p><strong>Winter</strong></p></td><td><p>Influenza, adenovirus</p></td><td><p>Respiratory viruses</p></td></tr><tr><td><p><strong>Geographic Location</strong></p></td><td></td><td></td></tr><tr><td><p><strong>Southwest US</strong></p></td><td><p>WNV</p></td><td></td></tr><tr><td><p><strong>Central US</strong></p></td><td><p>WNV, LACV</p></td><td></td></tr><tr><td><p><strong>Eastern/Southeast US</strong></p></td><td><p>WNV, EEEE, LACV</p></td><td></td></tr><tr><td><p><strong>Great Lakes/Northeast US</strong></p></td><td><p>WNV, Powassan, Borrelia, LACV</p></td><td></td></tr><tr><td><p><strong>International travel (endemic areas</strong></p></td><td><p>Rabies, JEV, TBEV, Measles</p></td><td><p>TB, dengue, chikungunya, Zika, Plasmodium</p></td></tr><tr><td><p><strong>Animal Exposure</strong></p></td><td></td><td></td></tr><tr><td><p><strong>Bat or skunk bite</strong></p></td><td><p>Rabies</p></td><td></td></tr><tr><td><p><strong>Rodent</strong></p></td><td><p>LCMV</p></td><td></td></tr><tr><td><p><strong>Cat</strong></p></td><td><p>Bartonella henselae</p></td><td></td></tr><tr><td><p><strong>Mosquito</strong></p></td><td><p>WNV, LACV, EEEV, SLEV</p></td><td></td></tr><tr><td><p><strong>Tick</strong></p></td><td><p>Powassan</p></td><td><p>Rickettsia, Ehrlichia, Anaplasma, Borrelia burgdorferi</p></td></tr><tr><td><p><strong>Activity</strong></p></td><td></td><td></td></tr><tr><td><p><strong>Freshwater swimming</strong></p></td><td><p>N fowleri, acanthamoeba</p></td><td></td></tr><tr><td><p><strong>Eating unpasteurized dairy</strong></p></td><td><p>Listeria monocytogenes</p></td><td><p>Toxoplasma, brucella, Coxiella</p></td></tr><tr><td><p><strong>Eating undercooked meat</strong></p></td><td></td><td><p>Toxoplasma</p></td></tr><tr><td><p><strong>Clinical Findings</strong></p></td><td></td><td></td></tr><tr><td><p><strong>Vesicular rash</strong></p></td><td><p>HSV, VZV, EV</p></td><td></td></tr><tr><td><p><strong>Lymphadenopathy</strong></p></td><td><p>Generalized: EBV, CMV, HIV</p><p>Localized: bartonella</p></td><td></td></tr><tr><td><p><strong>Respiratory symptoms</strong></p></td><td><p>Mycoplasma, influenza, adenovirus</p></td><td><p>Respiratory viruses</p></td></tr><tr><td><p><strong>Retinitis/keratitis</strong></p></td><td><p>WNV, CMV, bartonella</p></td><td><p>Toxoplasma gondii, reponema pallidum, toxocara canis/cati</p></td></tr></tbody></table></div><p><strong>References: </strong></p><p>- Messacar K et al. Encephalitis in US Children. Infect Dis Clin N Am. 2017. </p><p>- Gaensbauer HT et al. Neuroinvasive Arboviral Disease in the United States. Pediatrics. 2014. </p><h1 id=\"covid-19-and-neurologic-sequelae\">COVID-19 and Neurologic Sequelae</h1><p>Multisystem Inflammatory Syndrome in Children (MIS-C):</p><p>¬∑ An individual aged &lt;21 years presenting with fever*, laboratory evidence of inflammation**, and evidence of clinically severe illness requiring hospitalization, with multisystem (&gt;2) organ involvement (cardiac, renal, respiratory, hematologic, gastrointestinal, dermatologic or neurological); AND</p><p>¬∑ No alternative plausible diagnoses; AND</p><p>¬∑ Positive for current or recent SARS-CoV-2 infection by RT-PCR, serology, or antigen test; or exposure to a suspected or confirmed COVID-19 case within the 4 weeks prior to the onset of symptoms.</p><p>*Fever &gt;38.0¬∞C for ‚â•24 hours, or report of subjective fever lasting ‚â•24 hours **Including, but not limited to, one or more of the following: an elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, procalcitonin, d-dimer, ferritin, lactic acid dehydrogenase (LDH), or interleukin 6 (IL-6), elevated neutrophils, reduced lymphocytes and low albumin</p><p>Neurologic Presentations:</p><p>¬∑ CNS case presentations: Meningoencephalitis, Acute ischemic stroke (particularly LVO in patients &lt; 50y), Acute necrotizing encephalopathy, demyelinating disease, vertigo, headache, seizures, cerebellar ataxia</p><p>¬∑ PNS case presentations: anosmia and ageusia, Guillain-Barre syndrome and Miller-Fisher syndrome possible (tenuous evidence to support GBS and MFS associations, anosmia most common)</p><p>¬∑ ‚ÄúLong COVID‚Äù or ‚ÄúCOVID long-haulers‚Äù = description of increasingly recognized patient population who experience symptoms &gt; 28 days after viral infection. Commonly described symptoms are persistent myalgias, ‚Äúbrain fog‚Äù, headaches, generalized weakness, or dizziness.</p><p>References:</p><p>Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci. 2020;11(7):995-998. doi:10.1021/acschemneuro.0c00122</p><p>Fisicaro F, Di Napoli M, Liberto A, et al. Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective. Int J Environ Res Public Health. 2021;18(4):1415. Published 2021 Feb 3. doi:10.3390/ijerph18041415</p><p>Mendelson M, Nel J, Blumberg L, et al. Long-COVID: An evolving problem with an extensive impact. S Afr Med J. 2020;111(1):10-12. Published 2020 Nov 23. doi:10.7196/SAMJ.2020.v111i11.15433</p><p>LaRovere KL, et al. Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. JAMA Neurol. Published 2021 Mar 5. Doi:10.1001/jamaneurol.2021.0504</p>",
  "imageCount": 0,
  "chunkCount": 7
}